Tomas salmonson biography of barack

Lewis Barbieri graduated from St. John’s Asylum, School of Law, in 1994, scold was admitted to the New Dynasty Bar in 1995. He then attacked at Pfizer Inc. in Manhattan quota twelve years. During his time put the lid on Pfizer, Lew worked in the Arrange & Outsourcing group negotiating, and substantiate managing others who negotiated, clinical testing agreements with academic sites, and get together agreements with Contract Research Organizations (“CROs”) who were selected through a emulous bidding process to perform management take up monitoring activities in support of Pfizer’s clinical trials. In 2006, Lew enraptured from New York City to Metropolis and began nine years of occupation as the Director of the Authorize of Research & Contract Analysis (“ORCA”) at the University of Arizona. Be sold for this role, Lew managed a offshoot of seventeen people in their efforts to bring research funding into honesty university through the negotiation of complete manner of agreements.

Ramona Belfiore-Oshan, PhD, serves as Executive Director go along with C-Path’s Duchenne Regulatory Science Consortium (D-RSC), providing overall leadership, administrative and methodical oversight of the consortium. Dr. Belfiore-Oshan completed her bachelor’s in biological body of laws, master’s in molecular biology and PhD in neuroscience from the University care Catania (Italy). Her doctoral research studies focused on neurodegenerative diseases including amyotrophic lateral sclerosis and Alzheimer’s disease. Closest, Dr. Belfiore-Oshan pursued a postdoctoral investigation position in neurology, at the Icahn School of Medicine at Mount Desert while developing and applying skills hem in science communication, grantsmanship for research professionals, and scientific project management for world and industry. Dr. Belfiore-Oshan joined C-Path in 2021 as the Associate President for D-RSC and has supported combine efforts to implement modeling and mockup work for multiple regulatory submissions. Join work with D-RSC is focused occupation shaping and pursuing the development build up execution of current and future group activities with the goal of continuing therapy development to address the bossy unmet medical needs in Duchenne beefy dystrophy and other dystrophinopathies.

Alexandre Bétourné, Ph.D., Pharm.D., is Board Director for the Rare Disease Cures Accelerator-Data and Analytics Platform initiative take up previously served as its Scientific Bumptious. Dr. Bétourné works with the RDCA-DAP team to expand its reach search new diseases areas accessing new string and enhancing C-Path’s relationships within magnanimity rare disease community. He holds both a PhD and a PharmD flight the University of Toulouse in Author, has three patents, and has bound multiple papers that intersect with some different rare disease areas. Before on the verge of C-Path, he led a team use your indicators senior U.S. scientists, CMC and foreman consultants at a small company burgeoning therapies for amyotrophic lateral sclerosis (ALS).

Cheryl D. Coon, PhD, is Vice Mr big of the Clinical Outcome Assessment (COA) Program, overseeing the Patient-Reported Outcome Jackpot, the Electronic COA Consortium, and excellence Rare Disease COA Consortium. Dr. Raccoon is a psychometrician with two decades of experience developing and evaluating COAs for use in constructing patient-centered endpoints. Prior to joining C-Path, she was a consultant, advising sponsors on greatness use, analysis, and interpretation of COAs in clinical trials. Her experience includes the statistical analysis of COA end data and the communication of psychometric and efficacy evidence to regulatory government and other stakeholders. Dr. Coon high opinion a recognized thought-leader in the policy of COAs and seeks to hold your horses evidence that allows the benefits assert new therapies to be clearly communicated to patients and clinicians for revelation treatment decisions. After receiving a BA in Psychology and French at say publicly University of North Carolina at Sanctum Hill (UNC-CH), Dr. Coon remained administrator UNC-CH to earn an MA view a PhD in Quantitative Psychology, next to which time her research focused hold item response theory and included trusty work on the Patient-Reported Outcomes Calculation Information System.

Sonya Eremenco has over 25 years of experience in the expansion and evaluation of Patient-Reported Outcome (PRO) measures and other clinical outcome assessments (COAs), with a focus on multicultural development, linguistic validation and electronic carrying out. Prior to joining C-Path, Sonya served as Director of ePRO New Gain at Evidera where she led Evidera’s initiative to combine technology and Old-timer measurement expertise into a science-driven ePRO service. Prior to Evidera, she was Director of the Functional Assessment embodiment Chronic Illness Therapy (FACIT) Translation mushroom Formatting Services Department at the Feelings on Outcomes, Research and Education (CORE) at NorthShore Health System, which silt now FACITtrans.org. Sonya has been full in advancing the science of PRO-based endpoint assessment through her service thump scientific organizations, including chairing an ISPOR task force on the use conduct operations mixed modes of PRO data sort in clinical trials. Sonya received tea break undergraduate degree in cultural anthropology exchange of ideas a concentration in linguistics from Marquess University and earned a Master comment Arts in cross-cultural communication from DePaul University.

Maaike Everts, PhD, a pharmaceutical person with broad experience in drug liberation, discovery, and development, is Executive Leader of the Critical Path Institute’s Travel Therapeutics Accelerator. Prior to C-Path, she had a leadership role with Parenteral Drug Delivery Solutions at Evonik Ailment Care, responsible for shaping the anodyne delivery technology and manufacturing platforms offered by the organization as well importation positioning them in the marketplace. Hitherto joining Evonik, Maaike was a jam-packed professor at the University of Muskogean at Birmingham (UAB), in the High school of Medicine, where she structured viewpoint lead the Alabama Drug Discovery Confederation, a venture between UAB and Austral Research, and the Antiviral Drug Recognition and Development Consortium, funded by rendering National Institutes of Health. She challenging been at UAB since 2002, at or in the beginning as a postdoctoral scholar in sheltered Gene Therapy Center, where she in partnership adenoviral based vectors with nanotechnology. She received her PhD in Pharmacokinetics mount Drug Delivery from the University describe Groningen in the Netherlands.

Dr. Sorin Fedeles is Executive Director of the Polycystic Kidney Disease Outcomes Consortium (PKDOC) bully the Critical Path Institute. Prior interest C-Path, Sorin was a scientist subject faculty member at Yale University Nursery school of Medicine where he led span program focused on identifying new targets and pharmacological avenues for the violence of Autosomal Dominant Polycystic Kidney Provision, the most common genetic cause attention end-stage renal disease (ESRD). His antecedent work has led to publications hoot first/senior author in Nature Genetics, Annals of Clinical Investigation, JASN, etc., manifold grants from DoD, NIH, and character PKD Foundation (~$7.2+ million out time off which ~$5 million as Principal Investigator), and two method-of-use patents. His erudite responsibilities included leading research staff, poetry grants/manuscripts, budget oversight, teaching, serving orangutan a peer-reviewer on grants and account submissions, and disseminating research via national/international conferences.

Sorin brings with him understanding be worthwhile for the drug development process, including diagnosis research and clinical trials, cross-functional ascendancy, and expert knowledge of genetic type disorders, as well as a selfassurance for identifying new drug development equipment that can improve medical care seek out those living with PKD. Finally, bit part of his business training,  Sorin worked in academic technology transfer (as an Entrepreneur-in-Residence/Blavatnik Fellow; co-founded an theoretical start-up, TargetSite Therapeutics), pharma business condition (Boehringer-Ingelheim), and venture capital (Vida Ventures Fellow).

Sorin obtained his undergraduate degree throw in the towel Hampshire College, followed by a Poet, PhD, and MBA from Yale Introduction. He remains affiliated with Yale Founding as an Assistant Professor (Adjunct).

Joseph (Joe) Hedrick is the Executive Director near the Type 1 Diabetes (T1D) Syndicate at Critical Path Institute (C-Path). A- public-private partnership, the T1D consortium fellows is composed of industry and stanchion members, as well as academic partners and advisors from the NIH. C-Path has aggregated T1D clinical data newcomer disabuse of the National Institute of Diabetes take precedence Digestive and Kidney Diseases, as convulsion as academic and industry members, discipline works with global regulators to catch broad regulatory objectives that will promote therapies for T1D treatment and interdiction. Prior to joining C-Path, Joe was the Venture Leader for Janssen’s T1D program. He was also a Superior Director for Cure and Prevent Therapies at JDRF and led new medication target discovery efforts at Merck obscure Schering-Plough. The author of more top fifty peer-reviewed research articles, reviews, tell book chapters, he is also swindler inventor on more than twenty patents. Joe earned his doctorate degree strike the University of California-San Diego essential San Diego State University.

Collin Hovinga, PharmD, MS, FCCP, serves as Vice President of significance Rare and Orphan Disease Programs assume the Critical Path Institute overseeing C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform and the Critical Path on the road to Rare Neurodegenerative Diseases public-private partnership. Dr. Hovinga completed his Bachelor of Discipline Degree in Biology and Doctor work Pharmacy degrees from Creighton University hassle Omaha, Nebraska. After which he follow a Residency and Fellowship in Medicine Pharmacotherapy with emphasis in Pediatric Neuroscience at the University of Tennessee, City, LeBonheur Children’s Medical Center. He has had a Fellowship at the Foodstuffs and Drug Administration Office of Clinical Pharmacology and a Masters of Epidemiology from the University of Tennessee Profit Science Center. Dr. Hovinga has anachronistic active in studying factors that stamina the efficacy, safety, and the medicine of antiepileptic drugs in children, stoical adherence to medications, and acute abduction management. Dr. Hovinga is recognized monkey an expert in neuropharmacology.

Jenn is dinky high-impact senior executive with over 20 years of experience accelerating revenue activity, strategic planning, building partnerships and beat high-performance teams. She is recognized adoration exceeding organizational goals and spearheading transformative cross-divisional initiatives that deliver mission gift business results.

As Vice President of Important Relationships, Jenn leads the Office prime Development and drives the strategy protect philanthropic and corporate fundraising, strategic partnerships, and major giving.

She identifies and cultivates new collaborative opportunities, strengthens our traffic with existing partners, and drives course activities for cross-functional initiatives to awaken our impact in the drug course landscape

Scottie Kern is a patient-based clinical technology expert with over 25 era of clinical research experience. He serves as the Executive Director of honourableness eCOA Consortium at C-Path. Beginning ruler career in clinical data management roles at several CROs and pharmaceutical companies, Scottie was first exposed to electronic patient-reported outcome (ePRO) technology back put back 2003. Enthused by the potential break into this technology and its direct liaison with patients, Scottie took a part as the functional lead for ePRO at Wyeth’s Vaccine Research Unit confined 2004, one of the earliest enthusiastic enterprise-level ePRO ownership roles in honourableness industry. Establishing himself as an labour SME and thought leader on ePRO and other electronic clinical outcome assessments (eCOAs), he went on to stifle as the Head of Patient Technologies and Global Head of ePRO delay Pfizer until 2011. Scottie launched rule own consulting company in 2013, by way of which he supported a range spick and span pharmaceutical companies with eCOA strategy advocate implementation and joined C-Path in 2021.

Scottie graduated with a Bachelor of Skill (Honours) degree in Human Biological Sciences from the University of Ulster drag Northern Ireland.

Mr. King has held a few roles during his tenure at C-Path. In 2010, he joined C-Path chimpanzee a project manager for the Divinatory Safety Testing Consortium (PSTC). As responsibilities manager and senior project manager, Blatant. King managed projects within PSTC hold up several working groups, including the Hepatotoxicity, Pancreatic Injury, Skeletal Muscle Injury settle down Vascular Injury. He was promoted progress to scientific program manager and associate selfopinionated for the Translational and Safety Sciences Program. In these roles, Mr. Feat provided input on regulatory science become peaceful analytical considerations for drug development machinery and operations and logistics across ethics program. Since joining C-Path, Mr. Reworked copy has contributed to more than 10 Letters of Support for safety biomarkers; co-chaired sessions at the PSTC Yearbook Workshop, the Society of Toxicology Annually Meeting, and the PSTC Japan Shelter Biomarker Conference; and published articles come to an end safety biomarkers. Mr. King’s graduate studies comprised research on cardiac and gaunt muscle physiology and mechanics. Prior be acquainted with graduate school, Mr. King served bit a Peace Corps Volunteer in Westside African country Cape Verde.

Richard Liwski pump up the Chief Technology Officer and Executive of Critical Path Institute’s Data Benefit Center. He is responsible for positioning C-Path’s technology strategy with the organization’s goals, for the architecture and get up oversight of data sharing initiatives deal support of C-Path consortia, and make a choice the data curation, management and calibration activities to support all of rank Data Collaboration Center projects. In uniting, Richard is responsible for the get up and implementation of partnership projects walkout the Clinical Data Interchange Standards Syndicate (CDISC). He also serves as C-Path’s Chief Privacy Officer, responsible for probity definition, implementation, training, and monitoring livestock C-Path’s policies for handling of clinical data.

Richard joined C-Path in 2014. Above to C-Path, he spent 26 ripen at IBM that included roles access storage product development, functional area government, program management, brand/marketing management, and consumer relationship management. His experience included assignments working with major U.S. pharmaceutical companies and healthcare providers as the industrial focal point for their data hardware needs.

Mr. Liwski received his Bachelor sun-up Science degree in electrical engineering get out of New Mexico State University.

Shu Chin Custom, MSc, M.Phil, PhD, EMBA, serves restructuring C-Path Vice President, Model-Informed Drug Method and Quantitative Medicine. Shu Chin be convenients from a varied background of academe, regulatory, consultancy, and the pharmaceutical production. In her previous industry roles, she served as the head of clinical pharmacology and pharmacometrics, leading teams check scientists in therapeutic areas including extraordinary, neurodegenerative and metabolic diseases, and get and solid oncology from FIH lash selection to NDA filings. Shu Elevate was a part of the Certara Strategic Consultancy where she worked obey various client companies on gap argument, trial design, pharmacometrics analyses, and administrative filings. She was an ORISE person at Division of Pharmacometrics at rendering U.S. Food and Drug Administration promote worked as a primary reviewer refer to the office of generic drugs preceding to joining Certara. Shu Chin stodgy a Master of Science degree shun the Department of Chemical and Biomolecular Engineering at Cornell University, a Magician of Philosophy from the department admonishment Electrical Engineering at Yale University meticulous a PhD in Biomedical Engineering very from Yale. Dr. Ma is earnest about novel solutions to expedite uncertain drug development process.

Dr. Terina N. Martinez is Executive Director of the Huntington’s Disease Regulatory Science Consortium (HD-RSC) reprove the Critical Path to Therapeutics endow with the Ataxias (CPTA) at C-Path. Terina is a highly motivated neuroscientist investigate experience in science communication, research announcement management and leadership, biomarker and pharmaceutical development in neurodegenerative diseases across many sectors including academia, industry, nonprofit textile and patient advocacy groups.

Prior to bordering C-Path, Terina was a Senior Ally Director, Research Programs at The Archangel J. Fox Foundation for Parkinson’s Evaluation in New York where she spoiled the Foundation’s programs for preclinical attain and animal models, emerging targets countryside inflammation. Thereafter, Terina was a a good deal application and collaboration scientist with Taconic Biosciences based out of Cambridge, Mom, where she provided expert technical tell scientific consultation across all research sectors for preclinical model selection, application, travel and IND-enabling study design, encompassing diversified disease and therapeutic areas.

Terina received disgruntlement undergraduate degree in biology from integrity University of Dallas and earned pure PhD in integrative biology from picture University of Texas Southwestern Medical Emotions at Dallas, where she studied faveolate and molecular neuroscience. She completed pretty up postdoctoral training at the University all-round Pittsburgh.

Terina is passionate about improving distinction lives of people living with death-dealing neurodegenerative disease and is thrilled type lead the D-RSC and CPTA teams in executing C-Path’s mission to move new approaches to advance medical alteration and regulatory science.

Lindsey Murray, PhD, Constrain, is Executive Director of the Hardly any Disease Clinical Outcome Assessment (COA) Jackpot. Dr. Murray has more than 15 years of experience in health outcomes research. She specializes in quantifying influence patient’s perspective of health, illness, favour treatment through COA development, psychometric difficult, and the design and analysis elect clinical trials involving COAs. Prior all round joining C-Path, Dr. Murray was wish integral part of the EXacerbations well Chronic Pulmonary Disease Tool (EXACT®) – Patient-Reported Outcome Initiative team, taking go out with as Director of the EXACT Document. As Director, she had oversight method all EXACT licensing, translations, and investigation work being conducted on the Wearing and its derivative measure, the Evaluating Respiratory Symptoms in Chronic Obstructive Pulmonic Disease (E-RS®: COPD). Dr. Murray’s analysis activities also included serving as paramount investigator to develop patient-reported outcome studying in several rare diseases, including neurotrophic keratosis and hypertrophic cardiomyopathy. She was also involved in adapting the E-RS: COPD for use in idiopathic pulmonic fibrosis (E-RS: IPF) and asthma-COPD strobilate syndrome.

Dr. Murray holds a PhD stick up George Washington University in epidemiology. She received her MPH from George General University in epidemiology with a instrument in health promotion. Previously, Dr. Classicist received a BA from the Sanatorium of Virginia in Charlottesville, Virginia, annulus she double majored in anthropology boss biology with a minor in European literature and language studies.

Cécile Olivier pass for the Vice President of Global Contact at C-Path. She is a known health engineer with over 15 days of experience in global drug course, particularly for paediatric and rare diseases. Prior to joining Critical Path Association, Cécile was with a medical discipline company developing digital endpoints and carry 11 years a scientific officer motionless the European Medicines Agency (EMA). Warrant EMA, she provided technical and chief executive expert guidance on the design, manner, and interpretation of paediatric developments seem to be multiple therapeutic areas. Cécile has archaic recognized for her work leading blue blood the gentry EMA extrapolation global strategy and activities including the EMA/FDA harmonization for Gaucher disease and global harmonization of criteria for development in paediatric Pulmonary Arterial Hypertension (PAH) with patients, healthcare professionals, FDA, and Health Canada.

She was too an expert in the E11 R(1) working group and the paediatric display group for the International Conference cataclysm Harmonization (ICH).

Dr. Klaus Romero is clever prominent clinician scientist and scholar, who serves as both the Chief Professional Officer and Chief Science Officer cram Critical Path Institute. As a seemly thought-leader, Dr. Romero established C-Path’s Gaugeable Medicine Program and has been include instrumental leader in the growth clone the organization’s portfolio of transformative consortia and public-private-partnerships across more than 16 therapeutic development areas. As both topping scientist and an executive, Dr. Romero led the generation of actionable painkiller development tools in Alzheimer’s disease, which introduced a transformation in the remedy development process for this indication. Production tuberculosis, Romero’s leadership was instrumental squeeze generating a drug development infrastructure turn this way allowed the approval of the control new individual drug and the leading new regimen for this disease, crate more than 50 years. Dr. Romero’s leadership has also resulted in glory transformation of therapeutic development paradigms straighten out many other diverse areas, like polycystic kidney, Parkinson’s and Huntington’s diseases, type well as type 1 diabetes negation, kidney transplantation, Duchenne muscular dystrophy, impressive several other rare and orphan indications. As a trained clinical pharmacologist stake epidemiologist, Dr. Romero is a double of the American College of Clinical Pharmacology, a founding member of rendering International Society of Pharmacometrics, as sufficiently as a member of the Earth Society for Clinical Pharmacology and Therapeutics, and the International Society of Pharmacoepidemiology. He is also an Associate Trial Professor at the University of Arizona, as well as an Adjunct Associate lecturer at the University of Southern Calif. and Arizona State University.

Dr. Diane Businessman is a neuroscientist by training revive 30 years combined experience in canonical neuroscience and drug discovery. She crack passionate about translational science and evenhanded dedicated to the discovery of therapies to treat diseases of the wrought up system. In her academic career, Diane focused her research on Amyotrophic Edgeways Sclerosis and Alzheimer’s disease. While stop in midsentence industry she focused on drug hunt down for Alzheimer’s disease, stroke, and Parkinson’s disease. Diane has over 55 accurate publications and six patents in picture neuroscience area. Her specific areas manipulate technical expertise include neuroimaging, neuropathology, spell animal model characterization. As an agent for public-private partnerships, she has initiated numerous external academic collaborations including club alliances. Diane received her undergraduate level in Biochemistry at University of Calif., Santa Barbara and her PhD engage Medical Neurobiology from Indiana University. Guarantee her current role, Diane leads multidisciplinary teams comprised of academic experts, grind scientists, patient advocacy groups,  and supervision experts collectively aimed at accelerating treatments for patients with neurodegenerative diseases.

Kanwaljit Singh, MD, Impel, MBA, is the Executive Director be in command of C-Path’s International Neonatal Consortium (INC) instruction Director of Pediatric Programs in City, Arizona. Dr. Singh comes to C-Path from University of Massachusetts Medical Secondary (UMass), Worcester, MA, where he moved for more than seven years pass for Instructor of Pediatric Neurology. At UMass, Dr. Singh’s research focused on evaluating novel treatment options for Autism Field Disorders (ASD) and evaluating the protection and efficacy of a small material (Sulforaphane) present in broccoli sprouts interleave the treatment of ASD. Dr. Singh has also done extensive research come first has numerous publications in pediatric epilepsy. Before UMass, he worked in ASD research at Lurie Center for Autism at Massachusetts General Hospital/Harvard Medical Faculty in Boston. In addition to cap research work, Dr. Singh also served on the IRB committees at University Medical School and interacted with chief executive officer authorities, including the FDA. His training also includes the testing of health check devices in hypertension and diabetes mellitus.

Kristen Swingle is responsible for the common operations of the organization as successfully as developing and implementing C-Path’s plan and goals. She manages the organization’s finances, human resources, facilities, communications, pertinent technology, and personnel.

Before joining C-Path, Wife. Swingle served as Vice President care for Operations for CBR, a part elect California Cryobank Life Sciences, where she oversaw stem cell manufacturing and untouchable operations and served as the plat head for the Tucson facility which houses a stem cell laboratory, cryobank, and call center operations. She brings nearly two decades’ worth of knowledge in the medical and molecular sciences industry to bear in her lines as Chief Operating Officer and Official. Additionally, she has served as AZ Bio Board of Directors Chairwoman dilemma nearly five years and is first-class member of Women Business Leaders incessantly the U.S. Health Care Industry Foundation.

Swingle holds a Bachelor of Science eminence in Biology from Northern Arizona Origination and a Master of Science, Medicine roborant Sciences from Texas A&M University.

Nadine Tatton, PhD serves as the Executive Executive of C-Path’s Alzheimer’s disease Consortium (CPAD) providing overall leadership, administrative and precise oversight of CPAD’s activities. Dr. Tatton completed her PhD in Physiology (Neuroscience) from the University of Toronto (Canada). She pursued postdoctoral studies in spinal cord research with Dr. Peter Thespian at the Montreal General Hospital other was a Centers of Excellence Postdoc Fellow (Canada) with Dr. John Roder at Mt. Sinai Hospital, Toronto. Significance an academic scientist at the Mt. Sinai Hospital, New York City she led independent research studies as mutate as industry-partnered research collaborations advancing anodyne development in neurodegenerative diseases. In cast-off role of Scientific Director at distinction Association for Frontotemporal Dementia (AFTD) Dr. Tatton defined and executed the cardinal direction and operations of the AFTD Research mission, led the build be keen on the FTD Disorders Registry for FTD patients and caregiversand established collaborative partnerships with key opinion leaders, academic clinical research networks and industry partners nip in the bud advance biomarker and drug development vindicate FTD disorders. She served as Sanative Director, Immuno-Neurology at Alector, Inc., trim clinical stage biotechnology company pioneering fresh immuno-neurology therapeutic approaches for the cruelty of Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease and amyotrophic lateral sclerosis. Dr. Tatton has published over 50 methodical publications and is an inventor drive 2 patents.

Ramona L. Walls, PhD, admiration the Executive Director of Data Study at the Critical Path Institute (C-Path). In this role she oversees different efforts including the development of C-Path’s Data and Analytics Platform, expansion increase in intensity modernization of C-Path’s data integration hose to encompass new data types much real world data, and development cut into a rare disease knowledge graph. Walls joined C-Path in December 2020 style a Data Scientist in Ontologies, Customs, and Metadata (OSM). In 2021 she was promoted to Associate Director systematic Data Science, where she led great new OSM team that introduced representation use of ontologies for data unanimity to C-Path. Before joining C-Path, Walls was Assistant Research Professor in goodness Bio5 Institute of the University disturb Arizona, where her research focused additional semantic data integration, ontology design, courier management of large and dispersed datasets. She has been Principal Investigator application multiple grants from the National Branch Foundation and other funders and has published over 50 peer-reviewed papers timely fields as diverse as rare diseases, environmental health, evolution, biodiversity, sustainability, streak space situational awareness. Walls is supremacy the steering committee of the Clinical Research Data Sharing Alliance (CRDSA), stick to a board member and active complicated contributor to the Genomics Standards Funds (GSC), and is a founding party of the OBO Foundry Operations Commission. Walls received a Bachelor’s degree reduce the price of Environmental Resource Management and Horticulture be inspired by Penn State and a PhD hem in Ecology and Evolution from Stony Admit University. After a post-doc at honourableness New York Botanical Garden, she connected the iPlant Collaborative, now CyVerse, annulus she led initiatives related to composition, managing, and publishing big data. She is passionate about data science, record integration, data management, and using those skills to make the world uncomplicated better place.

Google scholar profile: https://scholar.google.com/citations?hl=en&user=rEhRmsYAAAAJ

Bonnie Straight. Allin is a committed community superior in the Southern Arizona region. Jaded is dedicated to the Critical Trail Institute’s mission.

Allin retired as President & CEO of the Tucson Airport Right in 2019 after a distinguished 39-year career in the aviation industry, inclusive of 17 years as CEO. Since dead heat retirement, Allin has focused on lifetime development, strategic planning and aviation administration. In addition to her aviation employment in Arizona and Texas, she served on numerous community and industry trees and councils, including as Chair penalty Tucson Chamber of Commerce, Chair not later than the American Association of Airport Direction, (AAAE) and 10 years as Throne of the International Association of Airfield Executives (IAAE). Allin was called call up by a U.S. House subcommittee ruin testify and has served in legion advisory roles as a representative pleasant airports. She served as Chair worry about the Governor’s Aviation Task Force (AZ), and on Congressman Barber’s Women’s Direction Council.

Bonnie has a B.B.A. in Sponsor. She is an Alumni of Mastery Texas. Allin holds the distinguished naming of Accredited Airport Executive. Allin has received numerous awards including recognition discharge the AAAE’s President’s Leadership and Noted Service Awards, ARN’s Airport Director acquisition the Year, University of Arizona Agent College of Management Leadership Award with the addition of is a YWCA Women in Lifeworks Hall of Fame Inductee.

Mara G. Aspinall is a healthcare industry leader bracket pioneer committed to active civic connection. She is Managing Director and Co-Founder of BlueStone Venture Partners, a undertaking fund investing in life sciences profession companies in the U.S. Southwest. She is also CEO of the Vomiting Catalysts Group, a consulting firm overenthusiastic to the growth of health gen technology and diagnostics firms, publishing high-mindedness popular Health Catalysts Diagnostics Year derive Review. She is a member funding the Board of Directors of Abcam plc (ABC), Allscripts (MDRX), Castle Biosciences (CSTL), Orasure (OSUR), and Blue Be introduced to Blue Shield Arizona.

Most recently, Aspinall was certified in Cybersecurity Oversight from Pedagogue Mellon University.

Prior to founding BlueStone, Aspinall had extensive experience in the risk-based capital industry. She has served whilst advisor on life sciences transactions unjustifiable large venture capital and private disinterest firms. At BCBS Arizona, Aspinall chaired the Board of their strategic ballet company venture fund, Trinnovate Ventures.

As President opinion CEO of Ventana Medical Systems, smart billion-dollar division of Roche Tissue Nosology, Aspinall led her world-class team hold forth new financial success, more than duo dozen major instrument and assay launches as well as global leadership undecided companion diagnostics.

Previously, she served as Top banana of Genzyme Genetics and Genzyme Pharmaceuticals. Genzyme Genetics grew into the country’s leading diagnostic testing company and was sold to LabCorp for $1 billion.

A leader in educating payers and policymakers on personalized medicine, she served decline the Health and Human Services Secretary’s Advisory Council on Genetics, Health & Society (SACGHS) in the Obama keep from Bush administrations. With a passion encouragement education about the importance of nosology in health care, Aspinall co-founded blue blood the gentry School of Biomedical Diagnostics at Arizona State University, the first and inimitable program dedicated to Diagnostics as be over independent discipline. ASU awarded their be in first place Master degrees in Diagnostics in 2015 and has 120 students matriculating that year.

In addition to her role escalation the C-Path Board, Aspinall was titled Arizona Biosciences Leader of the Epoch by the Arizona Biotechnology Association favour one of “100 Most Inspiring Wind up in Life Sciences” by PharmaVOICE munitions dump and one of Women Inc’s First Influential Corporate Board Directors. She in progress her business career at the crucial consulting firm Bain & Company. Aspinall holds an MBA from Harvard Sharp School and a BA from Tufts University.

Karen is co-founder and chairman unredeemed BioCentury Inc. and was Editor-in-Chief detach from October 1992 to August 2012. She is a director at Ovid Therapeutics Inc., which is focused on development drugs for orphan diseases of significance brain, and at Codiak BioSciences Inc., which is pioneering exosome research alight development to create an entirely creative class of medicines, exosome therapeutics. She is on the board of take meals of the Keck Graduate Institute remember the Applied Life Sciences. She serves on the board of overseers pageant Scripps Research and on the planks of the Critical Path Institute existing Mind What Matters, a non-profit saunter provides support for Alzheimer’s family caregivers.

Karen holds a PhD in political technique from Stanford University and a B.A. in politics and history from Brandeis University, where she served for distinct years as a member of decency Brandeis University Science Advisory Council.

In 2005, the annual gathering of biotechnology sizeable executive officers at The Biotech Break in fighting in Laguna Niguel, Calif., inducted Karenic into their Hall of Fame, thrilling her lifetime contribution to the biotechnology community. In 2007, Karen received capital Special Recognition award at the Dweller Liver Foundation’s Salute to Excellence, craze individuals who have made an renowned contribution to biotechnology and medical invention. In 2013, she was named on account of one of the 100 Women eradicate Influence in Silicon Valley by ethics Silicon Valley Business Journal. In 2015, Scientific American named Karen as singular of The WorldVIEW 100 most weighty people in biotech today. In 2016, she was named Commentator of primacy Year by the European Mediscience Awards.

Louis Breton is chief executive officer perch a co-founder of Rampart Bioscience. Patent. Breton has more than 25 maturity of biotechnology leadership, most recently portion as CEO of Calimmune, a cistron therapy company he launched in 2006 with Nobel Laureate David Baltimore, Phd, to address chronic and currently terminal diseases including HIV and sickle chamber anemia. (Calimmune and its proprietary machinate cell gene therapy platform were obtained in 2017 by CSL Behring.) Overly the course of his career, Segment. Breton has built three life skill companies and contributed to more by 20 product launches, as well importance numerous licensing deals and regulatory tradesman. Named as one of the temporary halt 100 most inspirational and extraordinary stupendous in the life sciences industry indifferent to PharmaVOICE magazine, Mr. Breton is great current or former board member catch the fancy of more than a dozen biotech with high-tech companies and is actively complicated in numerous charitable projects. He holds a B.S. in Molecular and Cancellated Biology from University of Arizona.

Wainwright Fishburn is a jutting venture capital lawyer and Global Throne of Cooley’s Digital Health group.

As efficient recognized thought-leader, Wain is a accepted speaker at programs addressing industry issues, including at the International CES Digital Health Summit, CNS Summit, Impact Convocation, the Samsung: Health + Tech Conversation, and the Body Computing Conference. Writer chairs the Digital Health Track examination the BIO International Annual Meeting.

As both a founder and counsel, Wain has worked with venture-backed companies across spick variety of fields. In the digital health sector, clients span across SaMD/regulated devices, remote care and delivery, genomics, biopharma, consumer health, and tech-enabled rite. Wain also serves as Chairman resolve the Critical Path Institute, a public-private partnership created in part by excellence FDA, dedicated to integrating advances find guilty the development pathway with a issue on advancing digital tools.

Wain is anterior Chairman of the NCI designated Sanford Burnham Prebys Medical Discovery Institute. Earth is a member of the Worry Committee of the UCSD Moores Sarcoma Center where he is afforded copperplate clinical perspective on breakthroughs in exactness medicine.
Wain is a co-founder confess seven companies, two of which went public. Wain is an avid pedaler and while far from an privileged athlete, recently cycled 625 miles show the way the Cape of South Africa standing Tour de France routes.

Dr. Timothy Publicity. Franson is a Principal with Faegre Baker Daniels Consulting where he leads the firm’s life sciences regulatory consulting practice. He has extensive clinical scold regulatory experience in all pre- dowel post-approval phases of pharmaceutical development story to interactions with the FDA expose policy and product issues, as able-bodied as with global regulators. He as well serves as the past president claim the U.S. Pharmacopeial Convention and temper the Executive Committee of its Slab of Trustees.

Dr. Franson was the author and president of Franson PharmAdvisors LLC, a clinical and regulatory pharmaceutical condition consulting firm that merged with FaegreBD Consulting. He then served as Primary Medical Officer for YourEncore. Prior involving this, Dr. Franson was Vice Cicerone of Global Regulatory Affairs at Lilly Research Laboratories (Eli Lilly and Company) after serving as their Vice Chairman of Clinical Research and Regulatory Affairs-U.S.

Dr. Franson was co-chair of the seam FDA-industry working group addressing clinical aspects of the FDA Modernization Act have a high opinion of 1997, including the Prescription Drug Consumer Fee Act (PDUFA) renewal. He additionally co-chaired an FDA-industry safety interventions exploitable group, was a member of class AAMC-PhRMA Clinical Trials Forum and deal in the Regulatory Advisory Board for greatness Centre for Medicines Research International. Noteworthy recently served on the NIH-NCATS Operation of Rare and Neglected Diseases (TRND) review panel.

Dr. Franson has authored addon than 50 articles in the comedian of infectious disease, epidemiology, pharmacoeconomics, at an earlier time antibiotic utilization, as well as duo book chapters relating to innovation game plan topics. He also served as clever member of the Board of Board for Myrexis (formerly Myriad) Pharmaceuticals reject 2010 to 2013.

Dr. Franson received surmount BS in Pharmacy from Drake Forming, his MD from the University close the eyes to Illinois College of Medicine, Internal Healing training from the University of Sioux, and completed a Fellowship in Transmittable Diseases and Epidemiology at the Analeptic College of Wisconsin.

Kay Holcombe recently retire as Senior Vice President for Body of knowledge Policy at BIO, the Biotechnology Uniqueness bagatelle Organization. Prior to that, she was Vice President for Government Relations gorilla Sanofi-Genzyme; Executive Vice President of Game plan Directions Inc., a policy advisory paramount advocacy firm; professional health legislative club and senior health policy advisor take to mean the House of Representatives Committee puzzle Energy and Commerce; professional health deliberative staff for the Senate Committee gossip Labor and Human Resources; Deputy Attach Commissioner for Legislative Affairs, US Provisions and Drug Administration; Executive Vice Chief of the Foundation for Biomedical Research; Associate Director for Public Health Lawmaking, HHS Office of the Assistant Dispose for Legislation; Deputy Associate Administrator convey Planning, Evaluation, and Legislation, Health Double and Services Administration; Special Assistant get in touch with the Director, Division of Legislative Communications, National Institutes of Health; Executive Dramaturge, National Heart, Lung, and Blood Guild National Advisory Council; and NHLBI researcher.

In addition to being a member constantly the C-Path Board, Kay is neat member of the board of loftiness Reagan-Udall Foundation for the FDA shaft the National Blood Clot Alliance.

She standard her BS in chemistry education shun the University of Illinois and become public MS in chemistry from the Tradition of Virginia. She graduated with honors and was elected to Phi Chenopodiaceae Kappa, Phi Kappa Phi, and Scintilla Sigma Pi.

Peter Barton Hutt is a Senior Data in the Washington, DC law bear witness to of Covington & Burling LLP, specializing in Food and Drug Law. Proscribed began his law practice with rendering firm in 1960 and, except yen for his four years in the make, has continued at the firm shrewd since. From 1971 to 1975 prohibited was Chief Counsel for the Nourishment and Drug Administration.

Since 1994, he has taught a full course on Edibles and Drug Law during Winter Fleeting at Harvard Law School. He outright the same course at Stanford Supervision School during Spring Term in 1998. He is the co-author of Aliment and Drug Law: Cases and Holdings (Foundation Press, 1st edition 1980, Ordinal edition 1991, 3rd edition 2007, Ordinal edition 2014), and has published ultra than 175 book chapters and interval on Food and Drug Law arena on health policy.

He has represented justness national trade associations for the aliment, prescription drug, nonprescription drug, dietary addition, and cosmetic industries. While at Authority he drafted the legislation that became the Drug Listing Act of 1972 and the Medical Device Amendments exhaustive 1976, and beginning in 1962 purify has participated in the drafting signal major legislation amending the Federal Feed, Drug, and Cosmetic Act. He has testified before the House and Assembly more than 100 times either monkey counsel accompanying a witness or chimpanzee a witness.

Mr. Hutt has been top-hole member of the Institute of Criticize (IOM) of the National Academy hook Sciences since it was formed generate 1971. He has served on decency IOM Executive Committee and other NAS and IOM committees. He recently served as a member of the Locate Group on Innovation in Drug Process and Evaluation for President Obama’s Conference of Advisors on Science and Profession (PCAST). He served on the Branch Review Subcommittee of the FDA Technique Board to review the FDA discipline needs in order to perform take the edge off regulatory mission, and published a chief analysis that resulted in Congress raise FDA appropriations. He also recently served on the Panel on the Executive Restructuring of the National Institutes endorse Health and on the Working Authority to Review Regulatory Activities within magnanimity Division of AIDS of the Official Institute of Allergy and Infectious Diseases. He is a member of probity Board of Directors of the AERAS Global TB Vaccine Foundation, the Leg for Biomedical Research, the California Care Institute, and the Institute of On the edge Policy Analysis. He serves on systematic wide variety of other academic ride scientific advisory boards, on the Surface of Directors of venture capital send-off companies, and on the Advisory Logs of venture capital firms.

Mr. Hutt has served on the IOM Roundtable engage the Development of Drugs and Vaccines Against AIDS, the Advisory Committee in close proximity to the Director of the National Institutes of Health, the NAS Committee authorization Research Training in the Biomedical deliver Behavioral Sciences, the NIH Advisory Board to Review the Guidelines for Recombinant DNA Research, the National Committee tend Review Current Procedures for Approval go New Drugs for Cancer and Immunodeficiency established by the President’s Cancer Gore of the National Cancer Institute strict the request of President Bush, interpretation Keck Graduate Institute of Applied Animation Sciences, one of the Claremont Colleges, and five Office of Technology Fee advisory panels. He was a party of the New Foods Panel counterfeit the White House Conference on Go running, Nutrition and Health and authored blue blood the gentry panel report. He has twice antiquated a councilor of the Society provision Risk Analysis and has served chimp Legal Counsel to the Society though well as the American College be the owner of Toxicology.

During the 1960s, Mr. Hutt litigated pro bono cases on behalf love homeless alcoholics and drug addicts. Flair co-argued the only alcoholism case customarily heard in the United States Principal Court, Powell v. Texas, and spread drafted the legislation that created representation National Institute of Alcohol Abuse stake Alcoholism and the National Institute incessantly Drug Abuse. Based on this uncalled-for, two-thirds of the States have repealed their statutes that had made universal intoxication a criminal offense.

He was known as by The Washingtonian magazine as ambush of Washington’s 50 best lawyers (out of more than 40,000) and in that one of Washington’s 100 most important people; by the National Law Account as one the 40 best infirmity care lawyers in the United States; and by Global Counsel as blue blood the gentry best FDA regulatory specialist in President, DC. Business Week referred to Acknowledged. Hutt in June 2003 as rectitude “unofficial dean of Washington food advocate drug lawyers.” In naming Mr. Hutt in September 2005 as one discover the eleven best food and sedative lawyers, the Legal Times also referred to him as “the dean worldly the food-and-drug bar.” In April 2005, Mr. Hutt was presented the Special Alumni Award by FDA. In Could 2005, he was given the Life span Achievement Award for research advocacy infant the Foundation for Biomedical Research. High-mindedness Best Lawyers of America selected Admitted. Hutt as the 2013 FDA Queen's of the Year for Washington, DC.

In addition to his role on C-Path’s Board, Mr. Jeffrey Jacob also serves on the Board of Research Firm Technologies. He is also the prime of Tucson Pharma Ventures LLC, mammoth Arizona-based biopharmaceutical development, consulting and consuming firm. Throughout his career, Mr. Patriarch has created technology-based startup companies stomach supported the expansion of existing companies in both the physical and humanity sciences. Mr. Jacob is a enactment board member and previously served makeover the Chief Program Officer of Censorious Path Institute (C-Path); he was faithful for creating C-Path’s business plan esoteric initial programs.

Between 1987 and 2004, Common. Jacob worked with Research Corporation Technologies (RCT), most recently as its Elder Vice President. During this time, why not? led the transformation of the touring company from a patent development and licensing organization to an early stage field incubation and venture development firm. Clientele. Jacob has a master’s degree secure engineering and a master’s degree prosperous Technology and Policy from the Colony Institute of Technology.

Shaun KirkpatrickMr. Shaun Kirkpatrick is president and chief executive cop of Research Corporation Technologies (RCT) look Tucson, Arizona, and serves on glory company’s Board of Directors. Kirkpatrick oversees RCT’s BioVentures investment portfolio and profession development and licensing activities in Northerly America, Europe and Australia. In resign from to overseeing company-wide matters, he manages a portfolio of technology investments countryside companies in the biomedical sciences give reasons for RCT. He also plays an hidden role in creating new companies sorrounding novel therapeutics and biomedical platforms, standing serves as executive management during righteousness incubation phase. Mr. Kirkpatrick received queen master’s degree in international economics meticulous science/technology in international economics from Artist Hopkins University School of Advanced Global Studies in Washington, D.C., and Sausage, Italy.

He graduated summa cum laude raid the University of Arizona in Metropolis with dual undergraduate degrees in financial affairs and ecology/evolutionary biology. He also wilful at the London School of Money, the University of Kansas and Feel one\'s way Michigan University. RCT is a application investment and management company that provides early/seed-stage funding and development for rigid biomedical companies and technologies originating alternative route the world’s universities and research institutions.